Cargando…
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
BACKGROUND: Event-free survival (EFS) has been listed on the FDA Table of Surrogate Endpoints as a surrogate measure that can be considered for accelerated or traditional approval in breast cancer. However, no studies have evaluated the correlation between the treatment effects on EFS and treatment...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910654/ https://www.ncbi.nlm.nih.gov/pubmed/33681740 http://dx.doi.org/10.1016/j.eclinm.2021.100730 |